Early research reported that naturally occurring variations of PPARα function influenced plasma lipid concentrations in type II diabetic patients but not healthy people, demonstrating that PPARα is a link between diabetes and dyslipidemia (68). This evidence concerns the gene PPARA and metabolic syndrome.